We are thrilled to be included on The Philadelphia Business Journal’s List of Business Networking Associations in the Philadelphia area. Thank you to our members, sponsors & partners for making this possible!
Click HERE to read more.
Dec28Mon
Growth to pick up by spring and latest round of stimulus may not be the last, PNC economist says
Philadelphia Business Journal
The $900 billion stimulus bill is crucial to supporting the U.S. economy “through a very difficult period” into early 2021, positioning economic growth to pick up by spring, the chief economist at one of the Philadelphia region’s largest financial institutions said.
After months of bickering, the House and Senate passed the legislation by early Tuesday.
Travis Manion Foundation Hosts Gala Honoring Resilience in 2020
PHILADELPHIA – December 10, 2020 – (Newswire.com)
Dec07Mon
Dec07Mon
Amicus Therapeutics Named a Great Place to Work-Certified™ Company in 2020
CRANBURY, N.J., Dec. 07, 2020 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused on discovering, developing and delivering novel medicines for rare diseases, today announced that it has been nationally recognized as a Great Place to Work-Certified™ Company in 2020. Great Place to Work® is the global authority on workplace culture, employee experience and leadership behaviors proven to deliver market-leading revenue and increased innovation. This Certification utilizes validated employee feedback based on the Great Place to Work’s data driven methodology and indicates that Amicus employees consistently acknowledge a positive work experience and value the overall corporate culture of the company.
Penn gene therapy pioneer ‘at full gallop’ with Regeneron on cocktail to prevent Covid-19
John George, The Philadelphia Business Journal
Gene therapy pioneer Dr. James Wilson and his team at the University of Pennsylvania have linked up with Regeneron Pharmaceuticals to test whether the New York biotechnology company’s combination therapy can prevent Covid-19 infections.
The research collaboration will investigate whether Regeneron’s casirivimab and imdevimab experimental antibody cocktail can prevent Covid-19 infection when delivered intranasally via Adeno-Associated Virus, or AAV, vectors developed at Penn.
Click HERE to read more.
